Deepak Bhatt, MD: Impact of COVID-19 on Clinical Trials in Cardiology


Deepak Bhatt, MD, offers perspective on how the ongoing pandemic has impacted clinical trials in the cardiovascular space.

This episode of the Practical Cardiology Podcast features an interview with Deepak Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, discussing clinical trials in cardiology during the ongoing pandemic.

The subject of the current interview is an article penned by Bhatt and other cardiologists addressing the impact the ongoing coronavirus disease 2019 (COVID-19) pandemic has had on cardiovascular trials in the United States, titled “The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19”.

A leading trialist involved in major trials including REDUCE-IT and THEMIS, Bhatt offers perspective on data from a professional and personal perspective on how the pandemic has, is, and will continue to affect clinical trials, with the ripple causing disruptions in treatment pipelines and the treatment of patients.

Related Videos
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Video 6 - "Evaluating Safety of Novel LDL Management Mechanism"
Video 5 - "Optimizing PCSK9 Inhibitors and Analyzing Plaque Reduction Data"
Video 4 - "Innovations in Small Interfering RNA (siRNA) Therapy"
© 2024 MJH Life Sciences

All rights reserved.